Schrodinger, Inc.

Schrodinger, Inc. (SDGR) priced its initial public offering on Feb 6, 2020 at $17.00 per share, above its $14.00–$16.00 range, raising $202M, and listed on Nasdaq Global Select. BMO Capital Markets was lead-left underwriter, joined by BofA Securities, Morgan Stanley and Jefferies. WilmerHale and Richards, Layton & Finger advised the company and Cooley advised the underwriters.

Schrodinger, Inc. sells a physics-based computational software platform used to discover molecules for drug development and materials applications. Customers include biopharmaceutical and industrial companies, academic institutions and government laboratories, and it also runs collaborative and internal drug discovery programs.

Status

IPO

Ticker

SDGR

Exchange

Nasdaq Global Select

Priced

Feb 6, 2020

IPO price

$17.00

Price range

$14.00–$16.00

Raised

$202M

First filed

Jan 10, 2020

Underwriters

BMO Capital Markets, BofA Securities, Morgan Stanley and Jefferies

Company counsel

WilmerHale and Richards, Layton & Finger

Underwriters' counsel

Cooley

Sector

Biotech & pharma

Country / state

NY